Recent advances in systemic and locoregional treatments for patients with unresectable or
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …

Cancer is one of the top life‐threatening dangers to the human survival, accounting for over
10 million deaths per year. Bioactive glasses have developed dramatically since their …

The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

The preferred treatment for hepatocellular carcinoma (HCC) is surgery, which is the only
way to achieve long-term survival and even a cure. However, the vast majority of patients …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) has limited treatment options;
long-term outcomes following intra-arterial radiation are unknown. We assessed clinical …

A multicenter analysis was conducted to evaluate the main prognostic factors driving
survival after radioembolization using yttrium‐90–labeled resin microspheres in patients …

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major
changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy …

Microsphere and particle technology represent the next-generation agents that have formed
the basis of interventional oncology, an evolving subspecialty of interventional radiology …

Chemoembolization and other ablative therapies are routinely utilized in downstaging from
United Network for Organ Sharing (UNOS) T3 to T2, thus potentially making patients …

PURPOSE: To standardize the indications, techniques, multimodality treatment approaches,
and dosimetry to be used for yttrium-90 (Y90) microsphere hepatic brachytherapy …